Accessibility settings

This paper is in the following e-collection/theme issue:

Prevention and Health Promotion (2313) Public (e)Health, Digital Epidemiology and Public Health Informatics (2395) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (286) HIV/AIDS/STI Prevention and Care (1309) Risky Sexual Behavior (193) Medication Adherence (180)

Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/71494, first published .
Four young Asian friends laughing while looking at a tablet

Tenofovir to Prevent HIV Infection in Western China: Pragmatic Randomized Controlled Trial

Tenofovir to Prevent HIV Infection in Western China: Pragmatic Randomized Controlled Trial

Authors of this article:

Yi Tao1 Author Orcid Image ;   Yan Zhang2 Author Orcid Image ;   Bin Peng2 Author Orcid Image ;   Aizhong Zeng3 Author Orcid Image ;   Jianghong Dai4 Author Orcid Image ;   Hao Liang5 Author Orcid Image ;   Juying Zhang6 Author Orcid Image ;   Huarui Shao2, 7 Author Orcid Image ;   Shihan Feng2 Author Orcid Image ;   Xiaoni Zhong2 Author Orcid Image ;   Ailong Huang2 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Xiao C, Qu K, He Q, Zhu Y, Yu Q, Zhai M, Li N, Hu R, Wu S, Yu B. Effectiveness, safety, adherence and risk compensation of oral pre-exposure prophylaxis (PrEP) in men who have sex with men: a systematic review and meta-analysis. BMJ Evidence-Based Medicine 2026:bmjebm-2025-113648 View